BioRestorative Therapies, Inc. (BRTX)
0.2132
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.2158
0.00 (0.00%)
After-Hours: 20:00
BioRestorative Therapies EPS Diluted (Quarterly) : -0.1215 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.1215 |
| December 31, 2025 | -0.3614 |
| September 30, 2025 | -0.3333 |
| June 30, 2025 | -0.3039 |
| March 31, 2025 | -0.639 |
| December 31, 2024 | -0.2364 |
| September 30, 2024 | -0.1344 |
| June 30, 2024 | -0.496 |
| March 31, 2024 | -0.3332 |
| December 31, 2023 | 0.2491 |
| September 30, 2023 | 0.3869 |
| June 30, 2023 | -1.469 |
| March 31, 2023 | -1.929 |
| December 31, 2022 | -1.186 |
| September 30, 2022 | -1.278 |
| June 30, 2022 | -1.285 |
| March 31, 2022 | -1.367 |
| December 31, 2021 | -5.796 |
| September 30, 2021 | -5.00 |
| June 30, 2021 | -5.12 |
| March 31, 2021 | -21.44 |
| December 31, 2020 | -12.64 |
| September 30, 2020 | -2.08 |
| June 30, 2020 | 7.20 |
| March 31, 2020 | -31.44 |
| Date | Value |
|---|---|
| December 31, 2019 | -79.68 |
| September 30, 2019 | -939.96 |
| June 30, 2019 | -949.72 |
| March 31, 2019 | -1138.28 |
| December 31, 2018 | -1296.68 |
| September 30, 2018 | -1579.00 |
| June 30, 2018 | -2120.00 |
| March 31, 2018 | -1560.00 |
| December 31, 2017 | -1280.00 |
| September 30, 2017 | -1480.00 |
| June 30, 2017 | -2040.00 |
| March 31, 2017 | -2240.00 |
| December 31, 2016 | -1750.72 |
| September 30, 2016 | -1720.00 |
| June 30, 2016 | -2240.00 |
| March 31, 2016 | -2760.00 |
| December 31, 2015 | -4360.00 |
| September 30, 2015 | -2280.00 |
| June 30, 2015 | -2560.00 |
| March 31, 2015 | -4000.00 |
| December 31, 2014 | -3497.60 |
| September 30, 2014 | -3200.00 |
| June 30, 2014 | -4800.00 |
| March 31, 2014 | -6400.00 |
| December 31, 2013 | -6840.80 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.4557 |
| CareDx, Inc. | 2.071 |
| Natera, Inc. | -0.4674 |
| Exagen, Inc. | -0.1323 |
| Sera Prognostics, Inc. | -0.181 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.154M |
| Revenue (Quarterly) | 0.0232M |
| Total Expenses (Quarterly) | 2.178M |
| Enterprise Value | 1.874M |
| Gross Profit Margin (Quarterly) | -157.8% |
| Profit Margin (Quarterly) | -9.29K% |
| Earnings Yield | -525.4% |
| Normalized Earnings Yield | -612.66 |